Vir Biotechnology, Inc.VIRNASDAQ
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-46.47%
↓ 321% below average
Average (30q)
21.05%
Historical baseline
Range
High:1171.00%
Low:-201.59%
Volatility
6520.2%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -46.47% |
| Q2 2025 | 15.14% |
| Q1 2025 | -19.12% |
| Q4 2024 | 49.35% |
| Q3 2024 | -45.81% |
| Q2 2024 | -98.09% |
| Q1 2024 | 42.39% |
| Q4 2023 | 25.55% |
| Q3 2023 | 13.22% |
| Q2 2023 | -50.09% |
| Q1 2023 | 4.74% |
| Q4 2022 | -177.19% |
| Q3 2022 | 186.57% |
| Q2 2022 | -122.22% |
| Q1 2022 | 77.32% |
| Q4 2021 | 1171.00% |
| Q3 2021 | -187.49% |
| Q2 2021 | 138.46% |
| Q1 2021 | -46.34% |
| Q4 2020 | -23.73% |
| Q3 2020 | -201.59% |
| Q2 2020 | 59.60% |
| Q1 2020 | -12.78% |
| Q4 2019 | -33.72% |
| Q3 2019 | -33.30% |
| Q2 2019 | -16.25% |
| Q1 2019 | -14.83% |
| Q4 2018 | 21.98% |
| Q3 2018 | -23.72% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |